{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T06:23:07Z","timestamp":1745907787124,"version":"3.37.3"},"reference-count":54,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T00:00:00Z","timestamp":1643500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001203","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001203","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["HO-19-20034"],"award-info":[{"award-number":["HO-19-20034"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Asthma"],"published-print":{"date-parts":[[2022,12,2]]},"DOI":"10.1080\/02770903.2021.2020813","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T04:04:41Z","timestamp":1643601881000},"page":"2375-2385","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Effectiveness of mepolizumab in patients with severe eosinophilic asthma: results from real-world clinical practice in Finland"],"prefix":"10.1080","volume":"59","author":[{"given":"Ville","family":"Koistinen","sequence":"first","affiliation":[{"name":"Allergy Center, Tampere University Hospital, Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Kauppi","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Diseases and Allergology, Helsinki University Hospital and Helsinki University, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juhana","family":"Id\u00e4np\u00e4\u00e4n-Heikkil\u00e4","sequence":"additional","affiliation":[{"name":"GSK, Espoo, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauri","family":"Veijalainen","sequence":"additional","affiliation":[{"name":"GSK, Espoo, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilona","family":"Iso-Mustaj\u00e4rvi","sequence":"additional","affiliation":[{"name":"MedEngine Oy, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tero","family":"Ylisaukko-oja","sequence":"additional","affiliation":[{"name":"MedEngine Oy, Helsinki, Finland"},{"name":"Center for Life Course Health Research, University of Oulu, Oulu, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juha","family":"Meht\u00e4l\u00e4","sequence":"additional","affiliation":[{"name":"MedEngine Oy, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arja","family":"Viinanen","sequence":"additional","affiliation":[{"name":"Pulmonary Diseases and Clinical Allergology, Turku University Hospital, Turku, Finland"},{"name":"Department of Pulmonary Diseases and Clinical Allergology, University of Turku, Turku, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maritta","family":"Kilpel\u00e4inen","sequence":"additional","affiliation":[{"name":"Pulmonary Diseases and Clinical Allergology, Turku University Hospital, Turku, Finland"},{"name":"Department of Pulmonary Diseases and Clinical Allergology, University of Turku, Turku, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,1,30]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00202013"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.06.048"},{"key":"CIT0003","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention 2020. Available from: https:\/\/ginasthma.org\/wp-content\/uploads\/2020\/04\/GINA-2020-full-report_-final-_wms.pdf [last accessed Jan 2021]."},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin20.600"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2011.03929.x"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.12.019"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2014.02.011"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00703-2018"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2005.11.020"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.2147\/jaa.s211246"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.05.032"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S40244"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2019.01.004"},{"key":"CIT0014","unstructured":"GlaxoSmithKline. Mepolizumab prescribing information (US). 2020. Available from: https:\/\/www.gsksource.com\/pharma\/content\/dam\/GlaxoSmithKline\/US\/en\/Prescribing_Information\/Nucala\/pdf\/NUCALA-PI-PIL.PDF [last accessed Jan 2021]."},{"key":"CIT0015","unstructured":"European Medicines Agency. 2021. Nucala EU prescribing information. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/nucala-epar-product-information_en.pdf [last accessed Jan 2021]."},{"key":"CIT0016","unstructured":"GlaxoSmithKline. Nucala: basic product information (Japan) 2020. Available from: https:\/\/gskpro.com\/ja-jp\/products-info\/nucala\/index\/ [last accessed Jan 2021]."},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60988-X"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403290"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30125-X"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2016.07.010"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.09.033"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2019.07.007"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01511-2019"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201502-0391LE"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01444-2018"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1159\/000375314"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-015-1023-4"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2019.101836"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00151-2020"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.03.042"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.7573\/dic.212584"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1080\/02770903.2019.1658208"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02345-2019"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2018.04.016"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1186\/s40733-020-00055-9"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(94)90036-1"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.06.053"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403291"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1111\/all.13370"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.12865\/chsj.46.01.09"},{"key":"CIT0041","unstructured":"Regeneron. Dupilumab prescribing information (US) 2021. Available from: https:\/\/www.regeneron.com\/sites\/default\/files\/Dupixent_FPI.pdf. [last accessed Jan 2021]."},{"key":"CIT0042","unstructured":"Genentech. Omalizumab prescribing information (US) 2019. Available from: https:\/\/www.gene.com\/download\/pdf\/xolair_prescribing.pdf. [last accessed Jan 2021]."},{"key":"CIT0043","unstructured":"AstraZeneca. Benralizumab prescribing information (US) 2021. Available from: https:\/\/www.azpicentral.com\/fasenra\/fasenra.pdf#page=1. [last accessed Jan 2021]."},{"key":"CIT0044","unstructured":"Teva Pharmaceuticals. Reslizumab prescribing information (US) 2019. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/0761033s010lbl.pdf. [last accessed Jan 2021]."},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13852"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00097-7"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708208"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30338-8"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.178558"},{"key":"CIT0050","unstructured":"U.S. National Library of Medicine. A study of benralizumab in patients with eosinophilic esophagitis (MESSINA) 2020. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04543409. [last accessed Apr 2021]."},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-020-00336-3"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1016\/j.anl.2018.07.011"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.2147\/jaa.s32232"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S236609"}],"container-title":["Journal of Asthma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/02770903.2021.2020813","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T14:10:38Z","timestamp":1668780638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/02770903.2021.2020813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,30]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12,2]]}},"alternative-id":["10.1080\/02770903.2021.2020813"],"URL":"https:\/\/doi.org\/10.1080\/02770903.2021.2020813","relation":{},"ISSN":["0277-0903","1532-4303"],"issn-type":[{"type":"print","value":"0277-0903"},{"type":"electronic","value":"1532-4303"}],"subject":[],"published":{"date-parts":[[2022,1,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijas20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijas20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-06-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}